Javascript must be enabled to continue!
Methaemoglobinemia Induced by MDMA?
View through CrossRef
Case. A 45-year-old man with a blank medical history presented at the emergency room with dizziness and cyanosis. Physical examination showed cyanosis with a peripheral saturation (SpO2) of 85%, he did not respond to supplemental oxygen. Arterial blood gas analysis showed a striking chocolate brown colour. Based on these data, we determined the arterial methaemoglobin concentration. This was 32%. We gave 100% oxygen and observed the patient in a medium care unit. The next day, patient could be discharged in good condition. Further inquiry about exhibitions and extensive history revealed that the patient used MDMA (3,4- methylenedioxymethamphetamine, the active ingredient of ecstasy).Conclusion. Acquired methaemoglobinemia is a condition that occurs infrequently, but is potentially life threatening. Different nutrients, medications, and chemicals can induce methaemoglobinemia by oxidation of haemoglobin. The clinical presentation of a patient with methaemoglobinemia is due to the impossibility of O2binding and transport, resulting in tissue hypoxia. Important is to think about methaemoglobin in a patient who presents with cyanosis, a peripheral saturation of 85% that fails to respond properly to the administration of O2. Because methaemoglobin can be reduced physiologically, it is usually sufficient to remove the causative agent, to give O2, and to observe the patient.
Title: Methaemoglobinemia Induced by MDMA?
Description:
Case.
A 45-year-old man with a blank medical history presented at the emergency room with dizziness and cyanosis.
Physical examination showed cyanosis with a peripheral saturation (SpO2) of 85%, he did not respond to supplemental oxygen.
Arterial blood gas analysis showed a striking chocolate brown colour.
Based on these data, we determined the arterial methaemoglobin concentration.
This was 32%.
We gave 100% oxygen and observed the patient in a medium care unit.
The next day, patient could be discharged in good condition.
Further inquiry about exhibitions and extensive history revealed that the patient used MDMA (3,4- methylenedioxymethamphetamine, the active ingredient of ecstasy).
Conclusion.
Acquired methaemoglobinemia is a condition that occurs infrequently, but is potentially life threatening.
Different nutrients, medications, and chemicals can induce methaemoglobinemia by oxidation of haemoglobin.
The clinical presentation of a patient with methaemoglobinemia is due to the impossibility of O2binding and transport, resulting in tissue hypoxia.
Important is to think about methaemoglobin in a patient who presents with cyanosis, a peripheral saturation of 85% that fails to respond properly to the administration of O2.
Because methaemoglobin can be reduced physiologically, it is usually sufficient to remove the causative agent, to give O2, and to observe the patient.
Related Results
Factors Underlying +/- 3, 4-Methylenedioxymethamphetamine Self Administration
Factors Underlying +/- 3, 4-Methylenedioxymethamphetamine Self Administration
<p>Rationale: +/- 3, 4-Methylenedioxymethamphetamine (MDMA; Ecstasy) consumption has increased globally over the past two decades. Human studies have demonstrated that in a s...
Central Basis For MDMA (ecstasy) Induced Hyponatremia
Central Basis For MDMA (ecstasy) Induced Hyponatremia
Clinical studies have shown that hyponatremia can be induced by the ingestion of the recreational drug MDMA (3,4-Methylenedioxymethamphetamine, ecstasy) when combined with a wate...
ΔFosB: A Molecular Mechanism of MDMA Dependence
ΔFosB: A Molecular Mechanism of MDMA Dependence
<p>Rationale. 3,4-methylenedioxymethamphetamine (MDMA) is a widely used illicit substance and some users show signs of abuse and dependence. It has been suggested that addict...
Elucidating the Cellular Effects of MDMA on the Serotonin Transporter (SERT)
Elucidating the Cellular Effects of MDMA on the Serotonin Transporter (SERT)
<p>Serotonin (5-HT) is a neurotransmitter with an integral role in regulating mood. Dysregulation of this system is implicated in disorders such as depression and withdrawal ...
Role of Microglia in 3, 4 Methylenedioxymethamphetamine (MDMA) -Induced Neurotoxicity: A Mini Review
Role of Microglia in 3, 4 Methylenedioxymethamphetamine (MDMA) -Induced Neurotoxicity: A Mini Review
MDMA (3, 4 Methylenedioxymethamphetamine) is a psychoactive drug under the amphetamine-type stimulant group. While the modulatory effects of MDMA on serotonin neurotransmission and...
Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria
Monoamine Oxidase-B Mediates Ecstasy-Induced Neurotoxic Effects to Adolescent Rat Brain Mitochondria
3,4-Methylenedioxymethamphetamine (MDMA)-induced neurotoxicity and the protective role of monoamine oxidase-B (MAO-B) inhibition were evaluated at the mitochondrial level in variou...
Wheel running increases hyperthermia and mortality rate following 3,4-methylenedioxymethamphetamine (MDMA) in rats
Wheel running increases hyperthermia and mortality rate following 3,4-methylenedioxymethamphetamine (MDMA) in rats
AbstractHyperthermic responses are commonly reported in cases of human medical emergency following recreational use of 3,4-methylenedioxymethamphetamine (MDMA, “Ecstasy”), but a pr...
Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis
Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis
Research suggests that methylenedioxymethamphetamine (MDMA)/`ecstasy' can cause serotonin depletion as well as serotonergic neurodegradation that may result in depression. This lon...

